Cargando…

Genetic, Clinical, and Laboratory Markers for DOCK8 Immunodeficiency Syndrome

DOCK8 immunodeficiency syndrome (DIDS) is a combined immunodeficiency characterized by recurrent viral infections, severe atopy, and early onset malignancy. Genetic studies revealed large, unique deletions in patients from different families and ethnic backgrounds. Clinical markers of DIDS include a...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Jeremiah C., Dove, Christopher G., Su, Helen C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835385/
https://www.ncbi.nlm.nih.gov/pubmed/21178272
http://dx.doi.org/10.3233/DMA-2010-0737
_version_ 1782292148737015808
author Davis, Jeremiah C.
Dove, Christopher G.
Su, Helen C.
author_facet Davis, Jeremiah C.
Dove, Christopher G.
Su, Helen C.
author_sort Davis, Jeremiah C.
collection PubMed
description DOCK8 immunodeficiency syndrome (DIDS) is a combined immunodeficiency characterized by recurrent viral infections, severe atopy, and early onset malignancy. Genetic studies revealed large, unique deletions in patients from different families and ethnic backgrounds. Clinical markers of DIDS include atopic dermatitis, allergies, cutaneous viral infections, recurrent respiratory tract infections, and malignancy. Immune assessments showed T cell lymphopenia, hyper-IgE, hypo-IgM, and eosinophilia. The impaired lymphocyte functions in DIDS patients appear central for disease pathogenesis.
format Online
Article
Text
id pubmed-3835385
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-38353852013-12-10 Genetic, Clinical, and Laboratory Markers for DOCK8 Immunodeficiency Syndrome Davis, Jeremiah C. Dove, Christopher G. Su, Helen C. Dis Markers Other DOCK8 immunodeficiency syndrome (DIDS) is a combined immunodeficiency characterized by recurrent viral infections, severe atopy, and early onset malignancy. Genetic studies revealed large, unique deletions in patients from different families and ethnic backgrounds. Clinical markers of DIDS include atopic dermatitis, allergies, cutaneous viral infections, recurrent respiratory tract infections, and malignancy. Immune assessments showed T cell lymphopenia, hyper-IgE, hypo-IgM, and eosinophilia. The impaired lymphocyte functions in DIDS patients appear central for disease pathogenesis. IOS Press 2010 2010-12-20 /pmc/articles/PMC3835385/ /pubmed/21178272 http://dx.doi.org/10.3233/DMA-2010-0737 Text en Copyright © 2010 Hindawi Publishing Corporation.
spellingShingle Other
Davis, Jeremiah C.
Dove, Christopher G.
Su, Helen C.
Genetic, Clinical, and Laboratory Markers for DOCK8 Immunodeficiency Syndrome
title Genetic, Clinical, and Laboratory Markers for DOCK8 Immunodeficiency Syndrome
title_full Genetic, Clinical, and Laboratory Markers for DOCK8 Immunodeficiency Syndrome
title_fullStr Genetic, Clinical, and Laboratory Markers for DOCK8 Immunodeficiency Syndrome
title_full_unstemmed Genetic, Clinical, and Laboratory Markers for DOCK8 Immunodeficiency Syndrome
title_short Genetic, Clinical, and Laboratory Markers for DOCK8 Immunodeficiency Syndrome
title_sort genetic, clinical, and laboratory markers for dock8 immunodeficiency syndrome
topic Other
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835385/
https://www.ncbi.nlm.nih.gov/pubmed/21178272
http://dx.doi.org/10.3233/DMA-2010-0737
work_keys_str_mv AT davisjeremiahc geneticclinicalandlaboratorymarkersfordock8immunodeficiencysyndrome
AT dovechristopherg geneticclinicalandlaboratorymarkersfordock8immunodeficiencysyndrome
AT suhelenc geneticclinicalandlaboratorymarkersfordock8immunodeficiencysyndrome